CAS: 1228650-83-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCR2 antagonist 5 REF: 54-BUP12157CAS: 1228650-83-6 | 98.79% | 931.00 €~4,078.00 € | Thu 24 Apr 25 |
 | CCR2 antagonist 5 REF: TM-T27682CAS: 1228650-83-6 | 98.79% | 99.00 €~2,405.00 € | Wed 11 Jun 25 |
Ref: 54-BUP12157
| 1g | 4,078.00 € | ||
| 25mg | 931.00 € | ||
| 50mg | 1,222.00 € | ||
| 100mg | 1,659.00 € | ||
| 200mg | 2,226.00 € | ||
| 500mg | 3,018.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
CCR2 antagonist 5
CAS:1228650-83-6
JNJ-41443532: oral hCCR2 antagonist, IC50=37 nM, anti-chemotaxis, treats inflammation & diabetes.
Formula:
C22H25F3N4O3S
Purity:
98.79%
Color and Shape:
Solid
Molecular weight:
482.52
Ref: TM-T27682
| 1mg | 99.00 € | ||
| 5mg | 235.00 € | ||
| 10mg | 354.00 € | ||
| 25mg | 635.00 € | ||
| 50mg | 902.00 € | ||
| 100mg | 1,225.00 € | ||
| 200mg | 1,644.00 € |
Estimated delivery in United States, on Wednesday 11 Jun 2025
